| DIRECT COMPETITOR COMPARISON | |
| QGLY | Pvt1 | MTXX | PRGO | Industry | | Market Cap: | 27.37M | N/A | 44.82M | 4.23B | 84.01M | | Employees: | 86 | 53,1001 | 34 | 7,250 | 38 | | Qtrly Rev Growth (yoy): | -21.70% | N/A | -26.50% | 15.90% | 3.00% | | Revenue (ttm): | 17.49M | 20.81B1 | 91.79M | 2.08B | 21.94M | | Gross Margin (ttm): | 53.86% | N/A | 72.36% | 30.24% | 63.53% | | EBITDA (ttm): | -6.73M | N/A | 10.07M | 365.56M | -6.12M | | Oper Margins (ttm): | -41.98% | N/A | 10.13% | 14.16% | -3.79% | | Net Income (ttm): | -7.59M | N/A | -10.79M | 163.82M | N/A | | EPS (ttm): | -0.587 | N/A | -1.203 | 1.793 | -0.19 | | P/E (ttm): | N/A | N/A | N/A | 25.83 | 16.47 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.04 | 1.15 | | P/S (ttm): | 1.56 | N/A | 0.49 | 2.03 | 4.23 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.21 | 0.00% | 56.92B | 12.69 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 54.09 | 0.00% | 15.64B | 18.10 | | Genzyme Corp. | GENZ | 54.87 | 0.00% | 14.56B | 31.28 | | Merck Serono S.A. | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.30 | 0.00% | 41.66B | 16.41 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 47.82 | 0.00% | 8.54B | 59.92 | | Teva Pharmaceutical Industries Limited | TEVA | 57.10 | 0.00% | 50.31B | 52.24 | | Sandoz International GmbH | Private - View Profile |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Watson Pharmaceuticals Inc. | WPI | 38.10 | 0.00% | 4.04B | 19.64 | | King Pharmaceuticals Inc. | KG | 11.44 | 0.00% | 2.84B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.68 | 0.00% | 5.40B | 108.47 | | Pfizer Inc. | PFE | 17.88 | 0.00% | 144.28B | 14.85 | | Johnson & Johnson | JNJ | 62.76 | 0.00% | 173.16B | 14.27 | | GlaxoSmithKline plc | GSK | 38.47 | 0.00% | 97.52B | 12.91 | | Sanofi-Aventis | SNY | 36.29 | 0.00% | 94.76B | N/A | | Novartis AG | NVS | 53.58 | 0.00% | 121.69B | 16.04 | | RHHBY.PK | 41.50 | 0.00% | N/A | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | AstraZeneca plc | AZN | 44.11 | 0.00% | 64.00B | 8.50 | | Abbott Laboratories | ABT | 53.35 | 0.00% | 82.52B | 14.44 | | Bristol-Myers Squibb Company | BMY | 24.25 | 0.00% | 48.04B | 4.51 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | PRGO | | [video] Private Club
Tue 6:51pm -
at CNBC | | • | PRGO | | PERRIGO CO Financials
Sat, Feb 6 -
EDGAR Online Financials | | • | PRGO | | Raytheon, Raymond James, Perrigo Hit Highs
Wed, Feb 3 -
at TheStreet.com | | • | PRGO | | 2 Stocks Hitting High Notes
Wed, Feb 3 -
at Motley Fool | | • | PRGO | | New Star Analyst Rankings for Perrigo Company
Wed, Feb 3 -
StarMine | | • | MTXX | | Matrixx Initiatives F3Q10 (Qtr End 12/31/09) Earnings Call Transcript
Tue, Jan 26 -
at Seeking Alpha | | • | MTXX | | Matrixx Initiatives, Inc. Fiscal 2010 Third Quarter Earnings Results Call scheduled for 11:00 am ET today
Tue, Jan 26 -
Shareholder.com | | • | MTXX | | New Star Analyst Rankings for Matrixx Initiatives Inc.
Tue, Jan 26 -
StarMine | | • | MTXX | | Dynavax, Matrixx: Early Volume Plays
Tue, Jan 26 -
at TheStreet.com | | • | MTXX | | MATRIXX INITIATIVES INC Files SEC form 8-K, Results of Operations and Financial Condition
Tue, Jan 26 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
1.52% Nasdaq 0.00%
Competitors
